Furthermore, it can stimulate the p53-p21 pathways, leading to cell cycle arrest and apoptosis of cancerous cells, suggesting a potential adjuvant role of these SCFAs in chemotherapy for GC [54]. This evidence concerns the gene TP53 and gastric cancer.